Inotuzumab (powder)
(Synonyms:英妥珠单抗)
目录号 : KM35813
CAS No. : 1660159-36-3
Inotuzumab (Humanized Anti-CD22 Recombinant Antibody) (powder) 是人源化的 IgG4κ 抗体靶向人 CD22。Inotuzumab (powder) 与毒性分子 Ozogamicin) 相连接可作为抗体-活性分子偶联物 (ADC),Inotuzumab ozogamicin 。Inotuzumab (powder) 可用于急性淋巴细胞白血病和非霍奇金淋巴瘤的研究。
Other Forms of Rapamycin:
KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
KKL 顾客使用本产品发表的 0 篇科研文献
暂无科研文献
| 生物活性 |
Inotuzumab (Humanized Anti-CD22 Recombinant Antibody) (powder) is a humanized IgG4κ antibody that targets human CD22. Inotuzumab (powder) can be linked to a toxic agent Ozogamicin as an antibody-drug conjugate (ADC), Inotuzumab ozogamicin . Inotuzumab (powder) can be used for the research of acute lymphoblastic leukemia and non-Hodgkin lymphoma.x
|
| 分子量 |
146.48 kDa
|
| CAS号 |
1660159-36-3
|
| 中文名称 |
英妥珠单抗
|
| 运输条件 |
Room temperature in continental US; may vary elsewhere.
|
| 储存方式 |
| Powder |
-20°C |
3 years |
| |
4°C |
2 years |
| In solvent |
-80°C |
6 months |
| |
-20°C |
1 month |
|